Research — APO Research, Inc.

EM is an abbreviation of “Effective Microorganism”, is a new compound microbial preparation, composed of photosynthetic bacteria, lactic acid bacteria, yeast, actinomycetes and other 10 more than 80 kinds of microbial compound culture from the flora, formed a complex and stable microbial system, mutual cooperation, the advantages of powerful, extremely powerful.

Types: EM 1 · EM
Applications: Agriculture · Animal Husbandry · Wastewater Treatment

5 editions2 January 2026

View 5 research editions

$4,950Single user · USD · Market Analysis & ForecastExplore product: Effective Microorganisms (EM)Compare research options for Effective Microorganisms (EM)

Pharma & Healthcare

Acidophilus Probiotic

Types: Tablets · Capsules · Others
Applications: Retailers · Online Shopping · Others

5 editions1 January 2026

View 5 research editions

$2,950Single user · USD · Industry ResearchExplore product: Acidophilus Probiotic Compare research options for Acidophilus Probiotic

Pharma & Healthcare

Micafungin Sodium for Injection

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.

Types: 50 mg Single-use Vial · 100 mg Single-use Vial
Applications: Candidemia · Respiratory Mycosis · Gastrointestinal Mycosis

5 editions22 December 2025

View 5 research editions

$3,450Single user · USD · Industry Growth & TrendsExplore product: Micafungin Sodium for Injection Compare research options for Micafungin Sodium for Injection

Pharma & Healthcare

Thymalfasin Drugs

Types: Original Drug · Generic Drug
Applications: Viral Hepatitis · Cancer · Other

5 editions27 December 2025

View 5 research editions

$4,950Single user · USD · Market Analysis & ForecastExplore product: Thymalfasin Drugs Compare research options for Thymalfasin Drugs

Pharma & Healthcare

Keyhole Limpet Hemocyanin (KLH)

This report studies the Keyhole Limpet Hemocyanin (KLH) market, KLH, which can be used as an active pharmaceutical ingredient (“API”), is a very large, high molecular weight, oxygen-carrying glycoprotein made of millions of atoms. There are two KLH subunit forms, KLH1 and KLH2, each composed of seven or eight functional units, with each functional unit having an oxygen binding site of two copper atoms. Keyhole limpet hemocyanin is an extremely large, heterogeneous…

Types: GMP/Clinic Grade · Research Grade
Applications: Laboratory · Pharmaceuticals

5 editions2 January 2026

View 5 research editions

$4,950Single user · USD · Market Analysis & ForecastExplore product: Keyhole Limpet Hemocyanin (KLH)Compare research options for Keyhole Limpet Hemocyanin (KLH)

Find your market.

9,053 topics, 45,265 reports

Canavan Disease Therapeutics

OTC Eye Drops and Lubricants Drugs

Cloxacillin

Metabotropic Glutamate Receptor 1

FSMP for Dietary Management of Preterm Infants and Low Weight Infants

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs

Erectile Dysfunction

Effective Microorganisms (EM)

Acidophilus Probiotic

Micafungin Sodium for Injection

Thymalfasin Drugs

Keyhole Limpet Hemocyanin (KLH)

Research series

Understand the research

Technology & industry

Materials & energy

Health & everyday life

Read by subject

Featured perspective

Find your research

Quick links